Risedronate metal complexes potentially active against Chagas disease.
Demoro B, Caruso F, Rossi M, Benítez D, Gonzalez M, Cerecetto H, Parajón-Costa B, Castiglioni J, Galizzi M, Docampo R, Otero L, Gambino D.
Demoro B, et al.
J Inorg Biochem. 2010 Dec;104(12):1252-8. doi: 10.1016/j.jinorgbio.2010.08.004. Epub 2010 Aug 14.
J Inorg Biochem. 2010.
PMID: 20817265
Free PMC article.
In the search for new metal-based drugs for the treatment of Chagas disease, the most widespread Latin American parasitic disease, novel complexes of the bioactive ligand risedronate (Ris, (1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonate), [M(II)(Ris)(2)].4H(2)O, where MCu …
In the search for new metal-based drugs for the treatment of Chagas disease, the most widespread Latin American parasitic disease, novel com …